Form 4 Filing for Joseph C. Papa

Joseph C. Papa, a director at Candel Therapeutics, Inc., acquired 32,000 stock options on June 23, 2026. These options, with an exercise price of $9.08, are subject to time-based vesting and will become exercisable by June 23, 2027, or the next Annual Meeting of Stockholders, provided Papa remains a director. The options expire on June 23, 2036. This transaction is reported on a Form 4 filing.